Observational study of pregnancy kit for rapid detection of pregnancy.

Not Applicable

Completed

• Registration Number: CTRI/2022/03/041516
• Lead Sponsor: Mankind Pharma Limited Mankind Pharma Limited

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Healthy female subjects of child-bearing age group of �18 to �50 years.

2. Who either request a pregnancy test, or require a pregnancy test for diagnostic studies or treatment.

3. Written informed consent from the subject, legally acceptable representative or parent and able to follow study procedures.

Exclusion Criteria

Subjects who are not able to or not willing to sign an IRB/IEC approved consent form.

2. Known pregnancy.

3. Symptomatic COVID-19 suspected subjects (as assessed by the COVID-19 Questionnaire).

4. Hemodynamically unstable.

5. Moderately to severely ill-appearing or in moderate to severe pain.

6. Technically not possible to obtain blood from the study subject.

Study & Design

• Study Type: PMS
• Study Design: Not specified